Indirectly recognized HLA-C mismatches and their potential role in transplant outcome

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Thus, Kirsten A ^a   Te Boome, Liane ^a   Kuball, Jürgen ^a   Spierings, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Epitopes; GvHD; Hla; HSCT; Indirect recognition; T lymphocyte; Transplantation immunology

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ALLELE; ANTIGEN RECOGNITION; ARTICLE; DONOR SELECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA MISMATCHING; HUMAN; RISK FACTOR; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 84905493810     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00210     Document Type: Article

References (30)

1. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med (1995) 6:2085-95. doi: 10.1084/jem.181.6.2085
2. Setini A, Beretta A, De SC, Meneveri R, Martayan A, Mazzilli MC, et al. Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum Immunol (1996) 2:69-81. doi:10.1016/0198-8859(96)00011-0
3. Shimizu Y, DeMars R. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol (1989) 9:3320-8.
4. Neefjes JJ, Ploegh HL. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol (1988) 5:801-10. doi:10.1002/eji.1830180522
5. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med (1992) 4:937-50. doi:10.1084/jem.176.4.937
6. Neisig A, Melief CJ, Neefjes J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol (1998) 1:171-9.
7. Schaefer MR, Williams M, Kulpa DA, Blakely PK, Yaffee AQ, Collins KL. A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages. J Immunol (2008) 12:7804-17. doi:10.4049/jimmunol.180.12.7804
8. Blais ME, Dong T, Rowland-Jones S. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology (2011) 1:1-7. doi:10.1111/j.1365-2567.2011.03422.x
9. Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2011) 6:885-92. doi:10.1016/j.bbmt.2010.09.012
10. Ho VT, Kim HT, Liney D, Milford E, Gribben J, Cutler C, et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 9:845-50. doi:10.1038/sj.bmt.1705315
11. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood (2004) 7:1923-30. doi:10.1182/blood-2004-03-0803
12. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood (2007) 13:4576-83. doi:10.1182/blood-2007-06-097386
13. Furst D, Muller C, Vucinic V, Bunjes D, Herr W, Gramatzki M, et al. High resolution HLA-matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood (2013) 122:3220-9. doi:10.1182/blood-2013-02-482547
14. Velardi A. Role of KIRs and KIR ligands in hematopoietic transplantation. Curr Opin Immunol (2008) 5:581-7. doi:10.1016/j.coi.2008.07.004
15. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet (2009) 9674:1550-61. doi:10.1016/S0140-6736(09)60237-3
16. Sypeithi. http://www.syfpeithi.de/bin/MHCServer.dll/FindYourMotif.htm. (2013)
17. Otten HG, Calis JJ, Kesmir C, van Zuilen AD, Spierings E. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. Hum Immunol (2013) 3:290-6. doi:10.1016/j.humimm.2012.12.004
18. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol (2007) 9:779-88. doi:10.1016/j.humimm.2007.04.005
19. Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 6:9. doi:10.1186/1745-7580-6-9
20. Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S. Prediction of proteasome cleavage motifs by neural networks. Protein Eng (2002) 4:287-96. doi:10.1093/protein/15.4.287
21. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2009) 1:1-13. doi:10.1007/s00251-008-0341-z
22. Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One (2007) 8:e796. doi:10.1371/journal.pone.0000796
23. Heemskerk MB, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FH, Doxiadis II, et al. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 3:193-200. doi:10.1038/sj.bmt.1705721
24. Spellman S, Klein J, Haagenson M, Askar M, Baxter-Lowe LA, He J, et al. Scoring HLA Class I Mismatches by HistoCheck Does Not Predict Clinical Outcome in Unrelated Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant (2012) 18:739-46. doi:10.1016/j.bbmt.2011.09.008
25. Fernandez-Vina MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood (2014) 123:1270-8. doi:10.1182/blood-2013-10-532671
26. Gilbert M, Paul S, Perrat G, Giannoli C, Pouteil NC, Morelon E, et al. Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. Transplant Proc (2011) 9:3412-4. doi:10.1016/j.transproceed.2011.09.023
27. Duquesnoy RJ, Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol (2002) 5:353-63. doi:10.1016/S0198-8859(02)00381-6
28. Duquesnoy RJ, Takemoto S, de LP, Doxiadis II, Schreuder GM, Persijn GG, et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation (2003) 6:884-9. doi:10.1097/01.TP.0000055101.20821.AC
29. Dankers MK, Witvliet MD, Roelen DL, de LP, Korfage N, Persijn GG, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation (2004) 8:1236-9. doi:10.1097/01.TP.0000120385.03278.28
30. Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant (2008) 9:1064-71. doi:10.1016/j.bbmt.2008.07.001